2021-04-19T11:54:44-05:00 2020-06-30 363321958 Desmond & Ahern Ltd 10827 S Western Avenue Chicago IL 60643 990 2019-07-01 366009467 Orthopaedic Research and Education Foundation ORTH 8476989980 9400 W Higgins Road No 215 Rosemont IL 60018 Joshua Jacobs MD Treasurer 8476989980 2021-04-19 1 Paul Betlinski P01960501 7737794720 2021-04-19 2019 2022-09-23 18:48:47Z OREF Richard Kyle MD 9400 W Higgins Road No 215 Rosemont IL 60018 8479993 0 X www.oref.org X 1955 IL Improving lives by supporting excellence in orthopaedic research. 20 20 14 200 0 0 3198011 3932349 0 0 474071 504463 0 0 3672082 4436812 2231583 2898801 0 0 1627891 1675389 0 0 740830 1087127 850754 4946601 5424944 -1274519 -988132 23718387 23173135 3974334 4510722 19744053 18662413 The Orthopaedic Research and Education Foundation (OREF) mission is improving lives by supporting excellence in orthopaedic research. OREF's vision is that it will be the leader in supporting orthopaedic research to improve function, eliminate pain and restore mobility. 0 0 3724036 2898801 Grant program: The purpose of OREF is to support research into the causes and treatment of musculoskeletal diseases and injuries. OREF's niche is supporting surgeon-researchers and PHD-researchers in basic science/translation, clinical, and health services research. OREF's education program offers new orthopaedic medical researchers the opportunity to develop their research interests and skills. Through educational programming, OREF supports emerging talent to help them successfully pursue research careers. 3724036 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 12 0 1 14 1 0 0 0 0 0 0 0 0 0 0 0 0 X 20 20 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CT DC DE FL GA IL IN KS KY LA MA MD ME MI MS MN MO MT NC ND NE NH NM NY OH OK OR PA RI SC SD TN UT VA WA WI WV WY X X Lee Grossman 8476989980 9400 W Higgins Road Rosemont IL 60018 Richard F Kyle MD President 5.00 X X 0 0 0 Joshua J Jacobs MD Treasurer 5.00 X X 0 0 0 Jeffrey S Abrams MD Chair, Corporate Advisory 5.00 X 0 0 0 David C Dvorak JD Trustee 5.00 X 0 0 0 Matthew B Dobbs MD Vice Chair-Grants 5.00 X 0 0 0 Francis Y Lee MD PhD Chair Grants 5.00 X 0 0 0 Michael L Parks MD Past President (ends 3/21) 5.00 X X 0 0 0 Richard F Santore MD Chair-Individual Developme 5.00 X 0 0 0 Mary Lloyd Ireland MD Trustee 5.00 X 0 0 0 Letha Y Griffin MD PhD Trustee 5.00 X 0 0 0 Thomas P Sculco MD President-elect 5.00 X X 0 0 0 David G Lewallen MD Past President (2019-2020) 5.00 X X 0 0 0 Christopher R Adams MD Trustee 5.00 X 0 0 0 Jeremie M Axe MD Trustee 5.00 X 0 0 0 B Sonny Bal MD JD MBA PhD Trustee 5.00 X 0 0 0 Nicholas M Bernthal MD Trustee 5.00 X 0 0 0 Eric V Dremel Trustee 5.00 X 0 0 0 Michael P Bolognesi MD Trustee 5.00 X 0 0 0 Karen L Hackett Trustee 5.00 X 0 0 0 Lawrence L Lenke MD Trustee 5.00 X 0 0 0 Timothy J Luchetti MD Trustee 5.00 X 0 0 0 Stuart Weinstein MD Trustee 5.00 X 0 0 0 Andrew N Pollak MD Trustee 5.00 X 0 0 0 Annuunziato Amendola MD Trustee 5.00 X 0 0 0 Daniel J Berry MD Trustee 5.00 X 0 0 0 Lee Grossman CEO 40.00 X 133088 0 19062 Carol Wargo Vice President of Corporat 40.00 X 156161 0 13960 Edward Hoover Senior VP of Development 40.00 X 145088 0 14859 Karen Pubentz Sr. Director of Communicat 40.00 X 125147 0 22409 Joanne P Ray Former CEO (ended 8/30/18) 40.00 X 98356 0 11112 657840 0 81402 5 1 1 0 0 3932349 3932349 467531 467531 4080113 4043181 36932 36932 36932 4436812 0 0 504463 2698801 2698801 200000 200000 281391 30953 160393 90045 1087960 357074 421749 309137 79465 24467 32154 22844 129975 41408 51430 37137 96598 27772 40732 28094 77262 23631 29926 23705 2358 1179 1179 19520 19520 31660 15830 15830 102617 43546 15620 43451 69404 16102 37845 15457 98401 28290 41493 28618 127871 30010 58745 39116 66164 26310 14648 25206 110209 74415 4636 31158 24335 6996 10262 7077 88093 65871 13151 9071 Bad debt 24880 12440 12440 Dues and subscriptions 7980 120 6595 1265 5424944 3724036 960078 740830 471 271 3965552 3573378 1976546 1880985 31654 40764 245168 190499 79004 54669 13069749 12482662 4595411 5140406 23718387 23173135 185244 175458 3168119 3767264 620971 568000 3974334 4510722 X 453327 662656 19290726 17999757 19744053 18662413 23718387 23173135 X -988132 -588569 495061 X X 0 1 X 1 0 X 5097325 4715824 5448193 3198011 3932349 22391702 5097325 4715824 5448193 3198011 3932349 22391702 2459778 19931924 805283 431365 506240 441988 467531 2652407 25044109 0.79590 0.78500 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 X 7961755 13785 -82175 -19900 7913265 8311807 35531 733712 1119295 7961755 8014335 46789 250683 8311807 7306263 10723 778493 81144 8014335 12835718 48562 953270 6230393 271935 28959 7306263 0 0 50447 31416 19031 130696 101628 29068 64025 57455 6570 54669 Charitable Remainder Trust Receivable 3385129 Cash Surrender Value of Life Insurance 1741193 Other receivables 14084 5140406 Due to Orthopaedic Partners 568000 568000 X 4387411 -588569 539168 -49401 4436812 0 4436812 5469051 44107 44107 5424944 0 5424944 Part IV, Line 2b: On behalf of other orthopaedic organizations, the Foundation accepts contributions for which it performs recordkeeping and provides grants requested by those organizations. Part X, Line 2: FIN48 Note from Audited Financial Statements The Foundation, an Illinois nonprofit corporation, is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code and applicable state law, except for taxes pertaining to unrelated business income, if any. The Foundation's annual information and income tax returns filed with the federal and state governments are subject to examination generally for three years after they are filed. The Foundation has adopted the requirements for accounting for uncertain tax positions and management has determined that the Foundation was not required to record a liability related to uncertain tax positions as of June 30, 2020. Part XI, Line 2d - Other Adjustments: Change in cash surrender value of life insurance policies -24,382. Change in charitable remainder trust receivable 563,550. Part XII, Line 2d - Other Adjustments: Orthopaedic partner endowment distribution 44,107. 0 0 0 0 0 0 0 0 0 0 North America Hypercoagulability After Hip Fracture as Determined by Thrombelastography 200000 0 0 0 0 0 0 Part III Accounting Method: 1 Columbia University Medical Center Sponsored Projects Administration Columbia University 630 West 168th New York NY 10032 135598093 501(c)(3) 20000 Inflammation in Rotator Cuff Tear and Repair Massachusetts General Hospital (The General Hospital Corp) 55 Fruit Street Boston MA 02114 042697983 501(c)(3) 299969 The Role of Brain Glial Activation in Persistent Pain Following TKA The Trustees of the University of Pennsylvania 3451 Walnut Street Franklin Building 5th floor Philadelphia PA 19104 231352685 501(c)(3) 20000 Achilles tendon response to varying degrees of exercise intensity. Johns Hopkins University-School of Medicine Office of Research Administration Broadway Research Building 733 N Br Baltimore MD 21205 520595110 501(c)(3) 20000 Topology Optimization of Hip Implants to Reduce Stress Shielding New York University School of Medicine Sponsored Programs Administration One Park Avenue 6th Floor New York NY 10016 135562308 501(c)(3) 20000 GIK in Preventing Musculoskeletal Injury After Trauma The Regents of the University of California (University of California Davis University of California Office of Research / Sponsored Programs 1850 Davis CA 95618 946036494 501(c)(3) 20000 Analysis of Tibial Contact in Kinematically Aligned TKA in Three Implants The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c)(3) 20000 The Role of the Long Head of the Biceps Tendon in Shoulder Stabilization The Regents of the University of California University of California San D 9500 Gilman Drive MC 0934 La Jolla CA 92093 956006144 501(c)(3) 20000 A Novel Treatment Strategy for Chronic Rotator Cuff Tears Washington University in StLouis Campus Box 1054 One Brookings Drive St Louis MO 631304862 430653611 501(c)(3) 10625 Connecting Community Context to Racial Disparities in Joint Replacement Stanford University Research Management Group 455 Broadway Discovery Hall 2nd Floor M Redwood City CA 940633126 941156365 501(c)(3) 5000 Healthcare Disparities in Pediatric Fracture Care Stanford University Research Management Group 455 Broadway Discovery Hall 2nd Floor M Redwood City CA 940633126 941156365 501(c)(3) 20000 Developing and Testing a Tool for Preference Elicitation in Carpal Tunnel Duke University Medical Center Suite 820 Erwin Square 2200 West Main Street Durham NC 27705 560532129 501(c)(3) 299997 Perioperative Antibiotic Prophylaxis in Patients Undergoing Elective TJA Cleveland Clinic Foundation PO Box 931531 Cleveland OH 44193 340714585 501(c)(3) 50000 Characterizing Cartilage Degradation Caused by Patellar Instability Temple University Of The Commonwealth System of Higher Education 1801 North Broad Street Philadelphia PA 191226003 231365971 501(c)(3) 5000 A Simple Test to Determine Ability to Drive after RLE Surgery The Research Foundation for The SUNY on behalf of University at Buffalo The UB Commons 520 Lee Entrance Suite 211 Sponsored Projects Servic Amherst NY 14228 141368361 501(c)(3) 5000 Impact of Standardized Opiate Prescribing on Number of Pills Prescribed University of Maryland Baltimore 620 W Lexington Street 4th Floor Baltimore MD 21201-1508 Baltimore MD 21201 526002033 501(c)(3) 225000 Therapeutic Application of Perivascular Stem Cells to Rotator Cuff Repair MAYO CLINIC ROCHESTER MN 200 First St SW Rochester MN 559050001 416011702 501(c)(3) 100000 Prospective Study of Vertebral Tethering vs. Fusion for Scoliosis Emory University 1599 Clifton Road NE 4th Floor Mailstop 1599-001-1BA Atlanta GA 30322 580566256 501(c)(3) 100000 Are Opioids Needed? Rush University Medical Center 1653 W Congress Parkway Chicago IL 60612 362174823 501(c)(3) 5000 RCT of Dilute Betadine Soak and Scrub for Foot and Ankle Surgery The Regents of the University of California San Francisco (Contracts & Gra UCSF Office of Sponsored Research 490 Illinois Street 4th Floor San Francisco CA 94143 946036493 501(c)(3) 5000 Characterizing Human FAPs to Decrease Fatty Infiltration of Rotator Cuff Rhode Island Hospital 593 Eddy Street Providence RI 029034923 050258954 501(c)(3) 5000 Promoting Cartilage Regeneration through DLX5 Modification of CPCs Washington University in StLouis Campus Box 1054 One Brookings Drive St Louis MO 631304862 430653611 501(c)(3) 5000 The use of biomarkers in pediatric musculoskeletal infections Beth Israel Deaconess Medical Center 330 Brookline Avenue E/BR 264 Boston MA 02215 042103881 501(c)(3) 5000 Biomechanical Testing of Proximal Humerus Fixation: A Novel Approach Rhode Island Hospital 593 Eddy Street Providence RI 029034923 050258954 501(c)(3) 20000 Long-Term Outcomes of ACL Reconstruction Surgery Washington University in StLouis Campus Box 1054 One Brookings Drive St Louis MO 631304862 430653611 501(c)(3) 50000 Patient factors associated with genetic markers for rotator cuff disease Dartmouth-Hitchcock Clinic One Medical Center Drive Lebanon NH 03756 222519596 501(c)(3) 47915 Intraoperative Ketamine for Pain Catastrophizing Arthroplasty Patients Carilion Medical Center 101 Elm Avenue Roanoke VA 24013 540506332 501(c)(3) 100000 When can patients safely drive after rotator cuff repair? Stanford University Research Management Group 455 Broadway Discovery Hall 2nd Floor M Redwood City CA 940633126 941156365 501(c)(3) 300000 Attacking Biofilm-associated Persister Cells Wake Forest University Health Sciences Medical Center Blvd WinstonSalem NC 27157 223849199 501(c)(3) 5000 Blood Flow Restriction Therapy For Shoulder Injuries in Baseball Players Vanderbilt University Medical Center Office of Sponsored Programs 3319 West End Avenue STE 970 Nashville TN 37203 620476822 501(c)(3) 5000 Determining Cell Lineage of Osteoblasts in Posterior Spinal Fusion Arizona Board of Regents University of Arizona P O Box 210158 Room 510 Tucson AZ 857210158 742652689 501(c)(3) 5000 Accuracy of Arthroscopic vs Open Reduction of Ankle Syndesmosis Injuries Allegheny-Singer Research Institute DBA AHN Research Institute 320 East North Avenue Pittsburgh PA 15212 251320493 501(c)(3) 5000 Biomechanical validation of shear wave elastography of the UCL The University of Iowa Office of the Vice President for Research Division of Sponsored Prog Iowa City IA 52242 426004813 501(c)(3) 240000 Bracing vs Casting in the Treatment of Idiopathic Early-Onset Scoliosis Scottish Rite for Children 2222 Welborn St Dallas TX 75219 750818178 501(c)(3) 240000 Translating Genomics into Early Onset Scoliosis Clinical Care Oregon Health & Science University 3181 SW Sam Jackson Park Rd Mail Code L106OPAM Portland OR 97239 931176109 501(c)(3) 50000 Quantification of fracture healing biology using novel collagen X bioassay The Pennsylvania State University College of Medicine Office of Research Affairs H138 500 University Drive Hershey PA 17033 246000376 501(c)(3) 98000 Mechanobiological Deficits in Allograft ACL Reconstructions New York University School of Medicine Sponsored Programs Administration One Park Avenue 6th Floor New York NY 10016 135562308 501(c)(3) 20000 Identification of Novel Fracture Healing Regulators The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c)(3) 20000 Flatfoot Deformity and Surgical Reconstruction in a Robotic Gait Simulator The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c)(3) 20000 Can bone turnover markers predict pseudarthrosis after ACDF? The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c)(3) 20000 The Role of Next Generation Sequencing in Assessing Eradication of PJI Cedars-Sinai Medical Center 8700 Beverly Boulevard 65-Wil Suite 1150 Los Angeles CA 90048 951644600 501(c)(3) 5000 The Impact of Faculty and Resident Diversity on Resident Attrition Louisiana State University Health Sciences Center-New Orleans 433 Bolivar St New Orleans LA 70112 726087770 501(c)(3) 18765 Integrating clinical, social and biological data to assess TKA risk Washington University in StLouis Campus Box 1054 One Brookings Drive St Louis MO 631304862 430653611 501(c)(3) 15000 Moving To Solutions: Understanding And Overcoming Orthopedic Disparities Anne Arundel Medical Center 2000 Medical Parkway Belcher Pavilion Suite 604 Annapolis MD 21401 521169362 501(c)(3) 16500 Improving Postop. Outcomes in African American Patients Undergoing TJA Part I, Line 2: The Research Grants Committee is responsible for allocating research funding to advance research in the specialty of orthopaedics and is empowered to establish criteria for the allocation and distribution of philanthropic funds to advance research in the specialty of orthopaedics, implement and conduct independent peer review process to select research funding recipients, prepare and distribute necessary promotional information and application forms for research grants and awards and to accept and allocate or decline to allocate, at its sole and absolute discretion, grants and awards for research. One-year grant recipients receive 50% of the funds to start, then 40% after a six-month financial report is received. A final scientific and lay report within 60 days after the grant ends along with a final financial report is required. Once OREF has the final reports the remaining 10% of the funds are released. One-time award/educational grant/lectureship grants receive full payment after they are approved. Documentation is in the file for lectureships, educational programs and awards. Two or three-year grants are paid and spread over the term of the grant. 10% is withheld until all of the reports are received. Multi-year grant recipients submit annual scientific reports which are then reviewed by the original peer review committee member. X X 1 0 0 0 0 0 0 0 0 Lee Grossman CEO 133088 0 0 0 0 0 9130 0 9932 0 152150 0 0 0 Carol Wargo Vice President of Corporat 156161 0 0 0 0 0 12362 0 1598 0 170121 0 0 0 Edward Hoover Senior VP of Development 145088 0 0 0 0 0 11537 0 3322 0 159947 0 0 0 Joanne P Ray Former CEO (ended 8/30/18) 98356 0 0 0 0 0 0 0 11112 0 109468 0 0 0 Part I, Line 4a Joanne Ray, former CEO, received severance upon leaving the Organization in August 2018. Severence of $98,356 was included in her 2019 W-2. Form 990, Part VI, Section B, line 11b The Finance Committee reviewed and approved the Form 990. It was provided to the Board of Directors, who had an opportunity to review the return prior to filing. Form 990, Part VI, Section B, line 12c All Trustees annual conflict of interest statements are on file with the OREF CEO. The CEO reviews meeting agendas prior to the meeting and notifies leadership of any issues that need to be addressed before the discussions take place. Any individual who gives notice of a potential conflict is to abstain from participation in discussions related to that item. Form 990, Part VI, Section B, line 15 The Foundation has a formal process to determine the compensation of its CEO. The process includes the following: 1) Review and approval by the Board of Trustees or Compensation Committee; 2) Use of comparable compensation data; 3) Contemporaneous documentation and record keepping. Form 990, Part VI, Section C, line 19 The Foundation made its governing documents, conflict of interest policy, and financial statements available to the public upon request for the period of disclosure set forth in IRC Section 6104(d). Form 990, Part XI, line 9: Orthopaedic partner endowment distribution -44,107. Change in cash surrender value of life insurance policies -24,382. Change in charitable remainder trust receivable 563,550. Form 990, Part XII, line 2c: The process has not changed from the prior year. Charitable Remainder Trusts Charitable trusts IL T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0